Conversely, RNA interference-mediated knockdown of p70S6K decreased the cellular proliferation of human glioblastoma cell lines U251 [49] and sensitized resistant colon cancer cells to selumetinib [50]. The gene discussed is RPS6KB1; the disease is colonic neoplasm.